- Home
- GXAI vs GELS Comparison
GXAI vs GELS Comparison
Compare GXAI & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- GELS
- Stock Information
- Founded
- GXAI 2021
- GELS 2018
- Country
- GXAI United States
- GELS Australia
- Employees
- GXAI N/A
- GELS N/A
- Industry
- GXAI
- GELS
- Sector
- GXAI
- GELS
- Exchange
- GXAI Nasdaq
- GELS NYSE
- Market Cap
- GXAI 7.6M
- GELS 7.7M
- IPO Year
- GXAI 2023
- GELS 2024
- Fundamental
- Price
- GXAI $1.14
- GELS $2.32
- Analyst Decision
- GXAI
- GELS
- Analyst Count
- GXAI 0
- GELS 0
- Target Price
- GXAI N/A
- GELS N/A
- AVG Volume (30 Days)
- GXAI 165.5K
- GELS 4.7M
- Earning Date
- GXAI 05-13-2025
- GELS 02-15-2025
- Dividend Yield
- GXAI N/A
- GELS N/A
- EPS Growth
- GXAI N/A
- GELS N/A
- EPS
- GXAI N/A
- GELS N/A
- Revenue
- GXAI $4,027.00
- GELS $95,618.00
- Revenue This Year
- GXAI N/A
- GELS N/A
- Revenue Next Year
- GXAI N/A
- GELS N/A
- P/E Ratio
- GXAI N/A
- GELS N/A
- Revenue Growth
- GXAI 1473.05
- GELS N/A
- 52 Week Low
- GXAI $1.00
- GELS $0.77
- 52 Week High
- GXAI $7.50
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- GXAI 47.93
- GELS N/A
- Support Level
- GXAI $1.00
- GELS N/A
- Resistance Level
- GXAI $1.18
- GELS N/A
- Average True Range (ATR)
- GXAI 0.10
- GELS 0.00
- MACD
- GXAI 0.00
- GELS 0.00
- Stochastic Oscillator
- GXAI 51.85
- GELS 0.00
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.